Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Prepaid Assets: 2017-2024

Historic Prepaid Assets for Aclaris Therapeutics (ACRS) over the last 8 years, with Dec 2024 value amounting to $12.0 million.

  • Aclaris Therapeutics' Prepaid Assets fell 32.41% to $4.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.2 million, marking a year-over-year decrease of 32.41%. This contributed to the annual value of $12.0 million for FY2024, which is 27.37% up from last year.
  • As of FY2024, Aclaris Therapeutics' Prepaid Assets stood at $12.0 million, which was up 27.37% from $9.5 million recorded in FY2023.
  • Aclaris Therapeutics' 5-year Prepaid Assets high stood at $13.5 million for FY2022, and its period low was $2.6 million during FY2020.
  • For the 3-year period, Aclaris Therapeutics' Prepaid Assets averaged around $11.7 million, with its median value being $12.0 million (2024).
  • As far as peak fluctuations go, Aclaris Therapeutics' Prepaid Assets skyrocketed by 401.74% in 2021, and later dropped by 29.96% in 2023.
  • Yearly analysis of 5 years shows Aclaris Therapeutics' Prepaid Assets stood at $2.6 million in 2020, then spiked by 401.74% to $13.0 million in 2021, then rose by 3.85% to $13.5 million in 2022, then fell by 29.96% to $9.5 million in 2023, then increased by 27.37% to $12.0 million in 2024.